Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.
伊利诺伊州北芝加哥 - 艾伯维公司(纽约证券交易所代码:ABBV)和Gedeon Richter Plc.宣布达成协议,共同发现和开发治疗神经精神疾病的新疗法。这项合作建立在近20年的合作伙伴关系基础之上,该合作关系已经产生了中枢神经系统疗法,包括cariprazine(VRAYLAR® / REAGILA®)和研究中的药物ABBV-932。
Secretary of State Antony J. Blinken said U.S. and Qatari negotiators would soon restart long-stalled negotiations, but that it remained unclear if Hamas was willing to engage. Sirajuddin Haqqani ...
Democratic presidential candidate Kamala Harris heads to the battleground of Georgia on Thursday for a star-studded rally featuring rock legend Bruce Springsteen, entertainer Tyler Perry and ...
Oct. 23, 2024 — Until now, researchers have been limited in developing photonic memory for AI processing -- gaining one important attribute like speed while sacrificing another like energy usage ...
If incumbency is an electoral advantage then the party is carrying a significant handicap as it approaches the starting line ...
The Central Bureau of Investigation (CBI) has moved the Supreme Court challenging the Karnataka government's decision to withdraw its consent to the probe agency for investigating a ...
IDF confirms the elimination of Hamas terrorist and UNRWA employee who on Oct 7 slaughtered civilians at a bomb shelter U.S. Special Envoy Amos Hochstein travels to Beirut for talks with Lebanese ...
Tesla CEO Elon Musk on Wednesday said the electric vehicle maker will roll out driverless ride-hailing services to the public in California and Texas next year, a claim likely to face significant ...
This content was published on Oct 24, 2024 On Thursday, the Swiss Federal Railways presented its first fully renovated InterCity tilting train (ICN). Read more: Swiss railways presents first fully ...
Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...